Literature DB >> 455249

Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases.

D R King, E E Lack.   

Abstract

The clinical and pathologic features of 49 patients with adrenal cortical carcinoma are presented. The series included 26 men and 23 women with a mean age of 34 years. The average duration of symptoms prior to diagnosis was 6.6 months. Eighteen patients (37%) presented with recognizable endocrine syndromes secondary to excess tumor steroid production. Surgical excision was the only mode of therapy to offer any opportunity for prolonged survival. Nine of the 21 patients (43%) with a completely resectable tumor were alive with no evidence of disease an average of 7.2 years postoperatively. Death due to metastatic tumor occurred in 36 of the 49 patients (73%) an average of 8.7 months following diagnosis. Chemotherapy had no apparent effect on outcome while radiotherapy produced an objective palliative response in 50% of treated patients. The average size and weight of the tumors were 12.4 cm and 875.6 g, respectively. The difficulty of precise pathologic classification of certain large adrenal tumors is discussed and the importance of histopathologic features relative to gross morphologic findings is emphasized.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455249     DOI: 10.1002/1097-0142(197907)44:1<239::aid-cncr2820440139>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

Review 1.  Current perspective in the diagnosis and treatment of adrenocortical carcinoma.

Authors:  D E Schteingart
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  An unusual case of adrenal cortical carcinoma.

Authors:  G R Mufti; J Farrell
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

3.  Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute experience.

Authors:  Clinton D Kemp; R Taylor Ripley; Aarti Mathur; Seth M Steinberg; Dao M Nguyen; Tito Fojo; David S Schrump
Journal:  Ann Thorac Surg       Date:  2011-10       Impact factor: 4.330

Review 4.  Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.

Authors:  Irina Veytsman; Lynnette Nieman; Tito Fojo
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

5.  Sonographic findings of adrenal cortical carcinomas in children.

Authors:  A Prando; S Wallace; J L Marins; R M Pereira; E R de Oliveira
Journal:  Pediatr Radiol       Date:  1990

6.  Fine needle aspiration biopsy of the adrenal gland: Cytological features and clinical applications.

Authors:  Kenneth C Suen; Norman H Chan
Journal:  Endocr Pathol       Date:  1992-12       Impact factor: 3.943

Review 7.  Adrenocortical carcinoma: the management of metastatic disease.

Authors:  André P Fay; Aymen Elfiky; Gabriela H Teló; Rana R McKay; Marina Kaymakcalan; Paul L Nguyen; Anand Vaidya; Daniel T Ruan; Joaquim Bellmunt; Toni K Choueiri
Journal:  Crit Rev Oncol Hematol       Date:  2014-06-04       Impact factor: 6.312

Review 8.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

9.  Coexistence of unilateral adrenal macronodule and Cushing's disease. Report of two cases.

Authors:  G Borretta; M Terzolo; F Cesario; I Meineri; A Pia; A Angeli
Journal:  J Endocrinol Invest       Date:  1996-02       Impact factor: 4.256

Review 10.  Incidentalomas of the adrenal gland: 36 operated patients and review of literature.

Authors:  J E Sirén; R K Haapiainen; K T Huikuri; A H Sivula
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.